Invention Grant
- Patent Title: Anti-ILT3 antibodies and antibody drug conjugates
-
Application No.: US16484238Application Date: 2018-02-09
-
Publication No.: US11267886B2Publication Date: 2022-03-08
- Inventor: Jaime Darce , Scott Michael Lonning , Nels Eric Pederson , Klarisa Rikova , Aleksandr Tkachev
- Applicant: Bluefin BioMedicine, Inc.
- Applicant Address: US MA Beverly
- Assignee: Bluefin BioMedicine, Inc.
- Current Assignee: Bluefin BioMedicine, Inc.
- Current Assignee Address: US MA Beverly
- Agency: McCarter & English, LLP
- Agent Marcie B. Clarke
- International Application: PCT/US2018/017546 WO 20180209
- International Announcement: WO2018/148494 WO 20180816
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/68 ; A61P35/00 ; A61K39/00
Abstract:
Disclosed herein are anti-immunoglobulin-like transcript-3 (ILT3) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
Public/Granted literature
- US20200031926A1 ANTI-ILT3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES Public/Granted day:2020-01-30
Information query
